Oppenheimer analyst Ken Wong initiates coverage on Squarespace (NYSE:SQSP) with a Perform rating.
Why ImmunoGen Shares Are Shooting Higher Today
ImmunoGen Inc (NASDAQ: IMGN) shares are shooting higher on Wednesday after it announced top-line data from the Phase 3 confirmatory MIRASOL trial (GOG 3045/ENGOT OV-55) evaluating Elahere (mirvetuximab soravtansine-gynx) compared to chemotherapy for folate receptor alpha (FRα)-positive platinum-r
